EBAY
50
-3
TAP
51
-2
HSIC
56
3
NRG
57
2
VZ
45
-2
TGT
50
2
MSI
69
-3
KMI
59
2
AMAT
49
-3
RIG
35
-3
TRIP
60
3
PEP
50
-4
WU
16
2
HBI
59
-2
AIZ
71
-2
VRSK
35
-3
VNO
59
3
IR
69
-2
PPL
60
-7
AVB
65
-2
EBAY
50
-3
TAP
51
-2
HSIC
56
3
NRG
57
2
VZ
45
-2
TGT
50
2
MSI
69
-3
KMI
59
2
AMAT
49
-3
RIG
35
-3
TRIP
60
3
PEP
50
-4
WU
16
2
HBI
59
-2
AIZ
71
-2
VRSK
35
-3
VNO
59
3
IR
69
-2
PPL
60
-7
AVB
65
-2
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
68.90
Seasonality Move:
2.56%

7 Day Trial

ALL ACCESS PASS

$ 7

How this hedge fund manager trades weekly options

Claim your free training on trading weekly options

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 28.4% based on the past 14 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $66.68. The Score for BIB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 28.4% based on the past 14 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
44
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
69.56
52-Week Low:
40.10

Prediction Charts

Market Cap:
0
Price in USD:
66.68
Volume:
9.5K
Beta:
1.84

Technical Analysis

SMA50:
65.28
SMA100:
61.21
SMA200:
58.39
52-Wk Change:
34.06%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 66.68 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-29 67.60 67.47 68.84 67.36
Aug-30 67.28 67.37 67.41 66.30
Sep-3 66.75 64.90 67.58 64.84
Sep-4 64.22 64.92 65.28 64.00
Sep-5 64.20 63.98 64.20 63.52
Sep-6 64.53 62.27 64.53 61.60
Sep-9 62.70 63.95 65.12 62.70
Sep-10 64.02 64.89 64.89 63.09
Sep-11 64.71 64.87 65.14 62.85
Sep-12 63.98 65.29 65.82 63.98
Sep-13 66.54 67.38 67.53 66.54
Sep-16 67.88 67.55 68.12 67.12
Sep-17 67.81 67.26 68.30 66.47
Sep-18 67.23 66.68 68.50 66.60

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.